Piyush Goyal addresses challenges faced by pharmaceutical exporters
NEW DELHI : In a significant move to bolster India’s pharmaceutical exports, Union Commerce and Industry Minister Shri Piyush Goyal convened a crucial meeting on Wednesday with key stakeholders from the pharmaceutical sector, including Mehul Shah, General Secretary of the Indian Drug Manufacturers Association (IDMA).
The discussions aimed at addressing the pressing challenges faced by pharmaceutical exporters, ensuring that India maintains its prominent position in the global market.
The meeting, attended by various industry representatives, focused on identifying the key hurdles that pharmaceutical exporters encounter.
With India being one of the largest suppliers of generic drugs worldwide, accounting for a substantial share of the global market, it is imperative for the sector to overcome these challenges to sustain growth and competitiveness.
The Minister’s office emphasized that the discussions were centered around exploring practical solutions that could enhance the industry’s performance on a global scale.
In a statement posted on X, the Minister’s office highlighted the collaborative spirit of the meeting. “Minister @PiyushGoyal held a meeting with Mehul Shah, General Secretary of the Indian Drug Manufacturers Association (IMDA) and other pharma industry stakeholders.
Discussions centred on addressing the challenges faced by pharma exporters and exploring potential solutions to further strengthen India’s position in the pharmaceutical sector globally,” the statement read.
Key issues discussed during the meeting included regulatory compliance, intellectual property rights, and the need for improved supply chain logistics.
The stakeholders underscored the importance of streamlining processes to ensure that Indian pharmaceutical products remain competitive in both quality and pricing.
The collaboration between the government and the industry was seen as crucial for fostering an environment conducive to innovation and growth.
Moreover, the discussions extended beyond immediate concerns, as participants outlined a long-term vision for solidifying India’s reputation as a leading pharmaceutical hub.
This vision includes investing in research and development, enhancing production capabilities, and promoting sustainable practices within the industry.
The Indian pharmaceutical sector plays a pivotal role in the country’s economy, not only providing essential medications domestically but also exporting to over 200 countries.
The Minister’s proactive engagement with industry leaders reflects the government’s commitment to supporting the sector and ensuring its continued success.
As India navigates the complexities of global trade, this meeting signals a concerted effort to address challenges head-on, paving the way for a stronger, more competitive pharmaceutical industry in the years to come.